Skip to content
ESC Cardio Talk cover art

All episodes

ESC Cardio Talk, 231 episodes. Page 3 of 3.

#
Title
201

Journal Editorial - Promoting physical activity in primary and secondary prevention

202

Journal Editorial - Development and validation of a multivariable prediction model for major adverse cardiovascular events after early stage breast cancer

203

Journal Editorial - Thromboembolic events around the time of cardioversion for atrial fibrillation.

204

ESC Congress - Results of the European Infective Endocarditis registry (ESC-EORP EURO-ENDO)

205

ESC Congress 2019 - Is perivascular fat a new cardiovascular risk factor? Results of SCOT-HEART

206

ESC Congress 2019 - DANAMI-2 - 16-year follow-up of the Danish Acute Myocardial Infarction 2 trial - Primary percutaneous coronary intervention versus fibrinolysis in ST-elevation myocardial infarction

207

ESC Congress 2019 - Residual Inflammatory Risk Associated with Interleukin-18 and Interleukin-6

208

ESC Congress 2019 - The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease, a cohort study

209

ESC Congress 2019 - Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial

210

ESC Congress 2019 - High penetrance and similar disease progression in probands and in family members with arrhythmogenic cardiomyopathy

211

ESC Congress 2019 - Relationship between hypoglycaemia, outcomes and empagliflozin treatment effect in EMPA-REG OUTCOME

212

Journal Editorial - Defining high bleeding risk in patients undergoing percutaneous coronary intervention

213

Journal Editorial - Transcatheter heart valve migration and embolization: rare and preventable?

214

Journal Editorial - Measuring coronary microvascular function: is it finally ready for prime time?

215

Journal Editorial - Longevity-associated variant BPIFB4 gene transfer to recapitulate healthy ageing in patients at risk: is the future around the corner?

216

Journal Editorial - PCSK9 inhibitors: what we know, what we should have understood, and what is to come

217

Journal Editorial - Continuous anticoagulation with catheter ablation: answers and questions

218

Journal Perspective - Cardiac arrest in takotsubo syndrome: results from the InterTAK Registry

219

Journal Editorial - Transcatheter pulmonary valve implantation: a melody to follow

220

Journal Editorial - Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry study

221

Journal Editorial - The future of functional mitral regurgitation treatment

222

Journal Editorial - Left ventricular non-compaction: have we reached the limits of conventional imaging?

223

Journal Editorial - Impact of Preoperative FFR on Arterial Bypass Graft Anastomotic Function: the IMPAG trial

224

Journal Editorial - Targeting RNA to lower triglycerides: long strides from short molecules 🎙️

225

Heart Failure 2019 - My Take Home Messages on novel treatments in heart failure on ESC-HF

226

EuroPrevent 2019 - Exercise and atrial fibrillation what to consider?

227

EuroPrevent 2019 - Sugar tax – The right answer on a complex metabolism

228

Journal Editorial - Blood pressure target in diabetics: how low is too low?

229

Journal Editorial - Cardiovascular Disease and Uric Acid

230

Journal Editorial - How to target vascular inflammation in the post-CANTOS era?

231

Journal Editorial - Atrial Fibrillation, with ACS and PCI: walking a tightrope

232

Lecture Series - Digital Health Revolution: The Rewards